Safety and Preliminary Efficacy of MOR103 in Patients With Active Rheumatoid Arthritis

Clinical trial NCT01023256 · COMPLETED

Trial details

NCT number: NCT01023256
Sponsor: MorphoSys AG
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2009-12-01
Primary completion: 2012-06-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.